| Nasdaq: ATRC
AtriCure, Inc. is a medical device company, which develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue for the treatment of atrial fibrillation and systems designed for the exclusion of the left atrial appendage. The company sells its products to hospitals and medical centers globally. It has two primary product lines for cardiac tissue ablation and a product line for left atrial appendage exclusion. The product lines for cardiac tissue ablation are AtriCure's Synergy Ablation System and Related Radio-Frequency Ablation Devices and Cryoablation System. The product line for left atrial appendage exclusion is AtriClip System. AtriCure was founded by Michael D. Hooven on October 31, 2000 and is headquartered in West Chester, OH.